Sharon Tetlow

Chief Financial Officer, CELL GENESYS INC.

Companies

Structure Therapeutics Inc.Board member Feb 2, 2023 to now¹
DICE Therapeutics, Inc.Board member Sep 14, 2021 to Aug 9, 2023²
GYRE THERAPEUTICS, INC.Board member Jan 17, 2020 to Jul 2, 2021³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

DICE Therapeutics, Inc.0 shares⁴Aug 9, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 9, 2023Returned to company 49,841 shares of DICE Therapeutics, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARStructure Therapeutics Inc., Board member
2
SEC EDGARDICE Therapeutics, Inc., Board member
3
SEC EDGARGYRE THERAPEUTICS, INC., Board member
4
SEC EDGARDICE Therapeutics, Inc. shares after the filing of Aug 9, 2023